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Two methods were employed to uncouple hepatic q-adrenergic re eptors from their associated G-protein (termed Gv) 
in order to determine whether locking of the ~l-receptor in a high-affinity agonist state at cold temperatures (2°C) repre- 
sents formation of a ternary complex. Uncoupling isdefined as the inability to observe the GppNHp-sensitive, high- 
affinity agonist state of the receptor in pH]prazosin competition binding studies performed at 25°C. The first method 
for achieving uncoupling involved brief alkalinization and resulted in greater than 95~; loss of several G-proteins. The 
second method involved proteolytic cleavage ofeither part or all of the ~-receptor coupling domain from the binding 
domain. Following either treatment, receptors were converted tothe high-affinity agonist state at 2°C. Thus, while forma- 
tion of the high-affinity state of the receptor at higher temperatures may require Gp, formation of this state at 2°C does 
not require Gp or even the entire ~-adrenergic receptor. 
ct 1-Adrenergic receptor; G-protein; Receptor affinity state; Competition binding; Conformational change; (Liver) 
1. INTRODUCTION 
In liver cells, oel-adrenergic receptors timulate 
polyphosphoinositide phospholipase C resulting in 
the formation of the second messengers inositol 
trisphosphate and diacylglycerol. There is now 
evidence that an IAP-insensitive GTP-binding 
regulatory protein (G-protein) termed Gp is in- 
volved in regulating the activation of phos- 
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Abbreviations: lAP, islet-activating protein, a Bordetella per- 
tussis toxin; PIP2, phosphatidylinositol 4,5-bisphosphate; Gp,
the hepatic GTP-binding regulatory protein which couples 
CaZ+-mobilizing hormone receptors to PIP2-phospholipase C; 
Gs and Gi, respectively, the stimulatory and inhibitory GTP- 
binding regulatory proteins of adenylate cyclase; SDS-PAGE, 
SDS-polyacrylamide gel electrophoresis; GppNHp, 5'-guanyl 
imidodiphosphate 
pholipase C (review [1]). Further evidence for this 
idea comes from studies which show that guanine 
nucleotides alter agonist affinity at al-adrener- 
gic receptors in competition radioligand-binding 
experiments [2-8] by analogy with fl-adrenergic 
receptors [9]. When these binding studies are 
conducted at 25-37°C, al-adrenergic receptor 
populations display two affinities for agonists and 
a single affinity for antagonist. A number of 
guanine nucleotides are capable of converting the 
higher affinity receptors to the low-affinity state 
[2-8]. It has been proposed that in analogy to 
fl-adrenergic receptors, the high-affinity state 
represents the formation of a ternary complex of 
agonist, receptor and Gp [9]. According to the 
ternary complex theory proposed by Delean et al. 
[10], the formation of this complex is agonist- 
induced and is presumably required for the 
stabilization of the high-affinity configuration. 
Our laboratory has previously reported that in- 
cubation of liver plasma membranes at 2°C con- 
verts Oel-adrenergic receptors into a homogenous 
population of sites which has a high affinity for 
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agonists which is insensitive to guanine nucleotides 
[6]. The Kd of  this state for agonists is similar to 
the high-aff in ity state observed at higher 
temperatures [6,9] which presumably  reflects the 
fo rmat ion  of  the ternary complex. However,  it was 
unclear f rom our study [6] or  the subsequent study 
by Schwarz and co-workers [9] whether the high- 
af f in i ty state observed at 4°C represented the ter- 
nary  complex.  Here, two methods were employed 
to uncouple hepatic t~l-adrenergic receptors f rom 
their associated G-prote in  (Gv) in order to deter- 
mine whether locking o f  the a l - receptor  in an 
agonist  high-aff in ity state (Kd -- 32--56 nM for 
epinephrine) at cold temperatures (2 -4°C)  
represents format ion  of  a ternary complex. Un- 
coupl ing is def ined as the inabi l i ty to observe the 
GppNHp-sens i t ive ,  high-aff in ity agonist state of  
the receptor  in compet i t ion binding studies with 
[3H]prazosin per formed at 25°C. Under  uncou- 
pl ing condit ions,  only the low-aff in ity agonist 
fo rm (Kd = 565 +_ 52 nM for epinephrine) of  the 
otl-receptor is observed and antagonist  b inding is 
not  altered. 
One method for uncoupl ing involves global  
removal  o f  G-proteins f rom the p lasma membrane 
by alkal in izat ion and the other involves proteolysis 
o f  the a~radrenergic receptor coupl ing domain  
f rom the binding domain.  Fo l lowing either treat- 
ment only the low-aff in ity agonist form of  the 
a~radrenergic receptor could be observed at 25°C, 
a l though the receptors could be completely con- 
verted to the high-aff in ity agonist form by cold 
temperature  incubat ion.  Thus, while format ion  of  
the high-aff in i ty form of  the receptor at higher 
temperatures may be indicative of  the ' ternary 
complex ' ,  fo rmat ion  of  this state at low 
temperatures does not require a G-prote in or even 
the complete a~radrenergic receptor.  
2. EXPERIMENTAL 
2. I. Materials 
Radiolabelled compounds were from New England 
Nuclear/Dupont (Boston, MA). Leupeptin and antipain were 
from Transformation Research (Framingham, MA). Sources of 
other materiais have been described previously [6,8,11]. 
2.2. Membrane preparation and l~H]prazosin-binding studies 
Liver plasma membranes were prepared from male Sprague- 
Dawley rats (200-250 g) and [aH]prazosin binding performed 
as described [6,8,11]. Computer analysis of binding data was 
performed as detailed in [6] using the mathematical modelling 
and curve-fitting capabilities of the RS-1 program (BBN Soft- 
ware, Cambridge, MA). In some experiments membranes 
prepared with 1 mM EGTA and protease inhibitors (I0/zg/ml 
leupeptin, 10/~g/ml antipain [8]) were alkalinized by resuspen- 
sion in ice-cold medium containing 25 mM Na2HPO4 (pH 11.9) 
and 1 mM EDTA for 45 min on ice with intermittent vortex- 
mixing [12,13]. The alkaline mixture was centrifuged at 30000 
x g for 10 rain and the membrane pellet was resuspended in
binding buffer (pH 7.4) with 1 mM EGTA and protease in- 
hibitors for use in various assays. These membranes are termed 
'alkalinized' membranes in the text. 
In other experiments, 4 mM CaCl2 was added and EGTA and 
protease inhibitors were omitted from the buffer used to wash 
and resuspend membranes following their isolation on the Per- 
coil gradient. Prior to use, these membranes were incubated for 
30 min at 25°C in order to allow proteolysis of the ~rl-receptor 
to occur [8]. Subsequently, the membranes were diluted 30-fold 
in medium containing EGTA and protease inhibitors, washed 
by centrifugation (30000 x g x 10 rain) and resuspended for use 
in various assays. These membranes are termed 'Ca2+-treated ' 
in the text. 
2.3. IAP-stimulated IsZP]ADP ribosylation and assay of 
PIP2-specific phospholipase C activity 
IAP-stimulated [32p]ADP incorporation i to the a-subunit 
of liver plasma membrane Giwas performed with repetitive ad- 
dition of [a2p]NAD, ATP and GTP as in [11]. PIP2-specific 
phospholipase C activity was measured in liver plasma mem- 
branes by measuring release of trichloroacetic acid-soluble 
radioactivity from exogenous [3H]PIP2, according to Taylor 
and Exton [14]. 
2.4. I~P]GTP photooffinity labelling 
For [32p]GTP photoaffinity labelling experiments, 20/~l pre- 
warmed (30°C) liver membranes (3-6 mg protein/ml) were 
added to 20/~l pre-warmed media in quartz tubes containing 
final concentrations of the following: 50 mM Na-Hepes (pH 
7.4), 10 mM MgC12, 1 mM EGTA, 5 mM ATP and 0.2/zM 
[ot-32p]GTP (3000 Ci/mmol). Non-specific binding was 
measured in the presence of 100/~M GTPyS, GppNHp or GTP 
and gave similar results. Following a 1 rain reaction the tubes 
were removed to ice and placed for 3 rain (4°C) in a Rayonet 
RPR-100 Photo Chemical Reactor (Southern New England 
UltraViolet, Hamden, CT) containing 16 lamps in a circular 
configuration generating 8W per lamp of 2537 A ultraviolet 
light. The tubes were placed in the reactor (1.5-2 inches from 
the lamp plane) on a rotating (5 rpm) carrier in order to ensure 
equal radiation of the samples. Subsequently, the samples were 
diluted to 1 ml in water and transferred toEppendorf tubes for 
precipitation with trichloroacetic a id (10% final concentra- 
tion). The precipitated proteins were solubilized and boiled in 
SDS-PAGE sample buffer prior to electrophoresis and 
autoradiography of the dried gels as in [8,11]. 
3. RESULTS AND DISCUSSION 
3.1. Effect o f  membrane treatments on GTP- 
binding proteins and PIP2-phospholipase C 
Citr i  and Schramm [12] reported that br ief  
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alkalinization of turkey erythrocyte membranes 
resulted in the inactivation of adenylate cyclase 
and Gs activity, but did not damage the B- 
adrenergic receptor. Similarly, alkalinization of 
platelet membranes resulted in loss of IAP- 
stimulated radiolabelling of the o~-subunit of Gi 
but did not significantly alter [3H]antagonist 
binding to inhibitory a2-adrenergic receptors [13]. 
In preliminary experiments, we characterized the 
effect of brief alkalinization on liver plasma mem- 
brane G-proteins. Fig. 1 (lanes 1,2) shows that brief 
alkalinization resulted in a greater than 95 °7o loss in 
the ability of IAP to incorporate [32p]ADP into 
the 41 kDa t~-subunit of Gi. 
Following UV light exposure, [a-32p]GTP 
became covalently attached to a number of liver 
plasma membrane peptides in the presence of 
5 mM ATP (fig. 1, lane 3). In the absence of high 
concentrations of ATP a greater number of sites 
were radiolabelled and no labelling was observed 
without UV light exposure or in the presence of 
1 o70 cholate (not shown). Photoaffinity labelling by 
[a-32p]GTP to 40-49 kDa liver membrane pep- 
tides (which may include the t~-subunits of G- 
proteins uch as Gs, Gi and Gv) could be abolished 
by excess GTP, GDP (not shown) or GTPTS 
(fig. 1, lane 4). These findings, plus the fact that the 
labelling was observed in the presence of a high 
concentration of ATP, indicate that the photoaf- 
finity radiolabelling resulted from the interaction 
of [a'-32p]GTP with guanine nucleotide-binding 
sites. In agreement with the IAP-stimulated 
[32p]ADP-ribosylation results, extensive loss of 
[a-32p]GTP photoaffinity labelling was observed 
in alkalinized membranes (fig.l, lanes 5,6). 
In order to measure specifically the IAP- 
insensitive G-protein which couples to Ca 2+- 
mobilizing hormone receptors, a functional assay 
was employed, namely GTPyS stimulation of 
PIP2-phospholipase C activity (table 1). Ca 2+- 
stimulated PIP2-phospholipase activity was also 
measured as an index of the membrane content 
of this enzyme. GTPyS-stimulated phospholip- 
ase C activity was abolished by alkalinization. 
Since the Ca2+-stimulated activity was also abOl- 
ished, loss of the GTP-rS activity cannot be attrib- 
uted necessarily to inactivation or loss of Op. 
Albeit the data from fig. 1 and previous studies 
[12,13], and the fact that a,l-receptors are 'un- 
coupled' following alkalinization (fig.2, see below), 
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Fig. 1. Effect of alkalinization on liver plasma membrane G- 
proteins. Autoradiographs are shown with the positions of the 
Mr standards indicated. IAP-stimulated [32p]ADP-ribosylation 
was measured using control (lane 1) and alkalinized membranes 
(lane 2). [o<-32p]GTP photoaffinity labelling of control (lanes 
3,4) and alkalinized (lanes 5,6) membrane peptides was 
accomplished as described in section 2. Membranes were 
incubated in the presence (lanes 4,6) or absence (lanes 3,5) of 
100/zM GTPyS for determination of non-specific 
radiolabelling. 
would tend to suggest that both Gp (indeed several 
G-proteins) and PIP2-specific phospholipase C are 
either inactivated, lost or both following alkalin- 
ization. 
We and others have previously described the 
mechanism of the uncoupling effects of Ca 2+ on 
the liver plasma membrane a't-adrenergic receptor 
[6,8,15]. This treatment had no signifcant effect 
on GTPTS and Ca2+-stimulated PIP2-specific 
phospholipase C (table 1) suggesting that, unlike 
the a,l-adrenergic receptor, these components are 
not a significant substrate for the endogenous 
Ca2+-sensitive protease that is co-isolated with the 
liver plasma membranes. 
3.2. Effect of  membrane treatments on otl- 
adrenergic receptor specific binding param- 
eters 
Fig.2 (top panel) shows the typical pattern of 
epinephrine competition for [3H]prazosin binding 
to al-adrenergic receptors at 25 and 4°C described 
previously [ 1,6-9,11,15]. Computer analysis of the 
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Table 1 
Effect of various membrane treatments on PIP2-phospholipase 
C activity a 
Membrane Assay conditions 
treatment (nmol [3H]PIP2 hydrolysed/mg protein 
per rain) 
0.2/zM Ca 2+ 0.2/~M Ca z+ 100#M Ca z÷ 
plus 
10/~M GTP~S 
Control 0.82 + 0.25 4.73 + 1.80 4.75 _+ 0.32 
Alkalinized N.A. N.A. N.A. 
CaZ+-treated 0.96 + 0.35 3.27 + 1.33 6.47 + 0.94 
PIP2-phospholipase C activity was measured in liver plasma 
membranes (25/~g protein/tube) according to Taylor and Exton 
[14] using exogenous [3H]phosphatidylinositol 4,5-bisphos- 
phate (0.1 mM, 697-812 cpm/nmol). Assays were for 15 rain 
at 37°C. The data are means + SE from 3 separate experiments 
with different membrane preparations. N.A., no activity 
detected 
data [2,6,9,15] indicates that the receptors are con- 
verted by GppNHp from a mixed population with 
higher affinity for epinephrine (61 _+ 2.4°7o of the 
sites had a Kd = 30 _+ 9) to a homogeneous popula- 
tion of sites with a single low affinity for 
ep inephr ine  (Kd = 637 +_ 70 nM). It is presumed 
that the high-affinity state represents formation of 
a ternary complex of agonist receptor and Gp [9] 
by analogy with/3-adrenergic receptors [10]. 
Fig.2 (middle panel) shows that alkalinization 
produced changes consistent with the uncoupling 
of eel-receptors from Gp, since no high-affinity 
receptors were observed at 25°C in the absence of 
GppNHp.  Instead, epinephrine interaction with 
crl-adrenergic receptors from alkalinized mem- 
branes could be described as binding to a 
homogeneous population of sites with a single low 
affinity for epinephrine (591 +_ 88 nM). GppNHp 
did not cause a further rightward shift in the 
binding. Similar effects of alkalinization on mem- 
brane/3-  and cr2-adrenergic receptors have been 
reported previously [12,13]. Fig.2 (bottom panel) 
shows that incubation of liver plasma membranes 
with Ca 2+ also resulted in an apparent uncoupling 
of Crl-adrenergic receptors from Gv [6,8,15]. This 
appears to be due to the ability of Ca 2+ to 
stimulate a leupeptin/antipain-sensitive protease 
co-isolated with liver plasma membranes [8,15]. 
Stimulation of this protease activity by Ca 2+ 
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Fig.2. Effect of different membrane treatments on epinephrine 
competition for [3H]prazosin binding to crl-adrenergic 
receptors. Equilibrium [3H]prazosin binding to control (top), 
alkalinized (middle) and Ca2+-treated (bottom) membranes was 
measured in the presence of various concentrations of 
epinephrine as described [6,8,11]. Tubes were incubated at 
25°C for 30 min (o,o) or 2°C for 3 h (×) in the presence ( ) 
or absence (o, ×) of GppNHp. The results hown are from a 
single experiment which is representative of two such studies. 
results in cleavage of the 78 kDa form of the 
Crl-adrenergic receptor to lower molecular mass 
forms ranging from 15 to 59 kDa [8,15]. This 
treatment has no significant effect on the apparent 
Kd or Bmax for [3H]prazosin binding [6,8]. Further- 
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more, the affinity of epinephrine in the presence of 
GppNHp is not significantly altered by this treat- 
ment. However, as seen in fig.2 (bottom panel), 
this treatment does result in uncoupling of the 
a~radrenergic receptors since no high-affinity 
agonist binding is observed at 25°C in the absence 
of GppNHp [6,8,15]. The apparent Kd for 
epinephrine in Ca2+-treated membranes at 25°C in 
the absence of GppNHp was 709 _+ 43 nM (fig.2, 
bottom panel). 
3.3. Effect of cold temperature incubation on 
ot l-adrenergic agonist binding 
Fig.2 shows that incubation at 2 -4°C converts 
a.l-adrenergic receptors to a homogeneous popula- 
tion of sites with a single high affinity for 
epinephrine (32 _+ 3 nM). Since guanine nucleo- 
tides do not affect this high-affinity configuration, 
it is stated that the Crl-adrenergic receptors are 
' locked' [6,9] into a high-affinity state at cold 
temperatures. Fig.2 shows further that incubation 
at 2°C resulted in conversion of the receptors to a 
homogeneous population of high-affinity sites 
even when they had been uncoupled by the two 
membrane treatments described above. The ap- 
parent Kd values measured at cold temperature 
were 32 _+ 3, 56 _+ 5, and 39 _+ 5, respectively, for 
control, alkalinized and Ca2+-treated membranes. 
Since al-adrenergic receptors are not capable of 
coupling to Gp in alkalinized or Ca2+-treated mem- 
branes (as shown by the binding data at 25°C; 
fig.2), our data indicate that the high-affinity 
a~l-agonist binding observed at cold temperatures is 
not representative of a ternary state of agonist, 
receptor and Gp. This conclusion is further sup- 
ported by studies on O~l-adrenergic receptors of 
BCaH1 [17] and DDT1MF-2 [18] cells. In these cells 
high-affinity o~-adrenergic agonist binding is 
observed at 2-4°C,  despite the fact that the 
Crl-adrenergic receptors appear to be uncoupled 
(i.e. no guanine nucleotide-sensitive high-affinity 
agonist binding is observed in equilibrium binding 
experiments). Since Ca 2+ treatment results in pro- 
teolysis of o~l-adrenergic receptors, our data also 
indicate that the formation of the high-affinity 
agonist state at cold temperatures does not require 
the entire trl-adrenergic receptor and therefore 
may be a function of the binding domain itself. 
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